Revolutionizing cancer immunotherapy: T cell engagers beyond hematologic malignancies toward solid tumors.
Saved in:
| Title: | Revolutionizing cancer immunotherapy: T cell engagers beyond hematologic malignancies toward solid tumors. |
|---|---|
| Authors: | Wu X; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Li P; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Department of Gastric Cancer Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Li T; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Fan Q; First Clinical Medical College, Xuzhou Medical University, Xuzhou, China., Wu H; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Department of Gastric Cancer Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 May 20; Vol. 17, pp. 1774471. Date of Electronic Publication: 2026 May 20 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
